(Q47394615)

15 January 2018

title

Low-molecular-weight heparins have no place in recurrent miscarriage: debate--for the motion (English)

1 reference

15 January 2018

main subject

miscarriage

0 references

recurrent miscarriage

1 reference

Saskia Middeldorp

1

1 reference

15 January 2018

publication date

1 February 2011

1 reference

15 January 2018

published in

Thrombosis Research

1 reference

15 January 2018

volume

127 Suppl 3

1 reference

15 January 2018

page(s)

S105-9

1 reference

15 January 2018

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Increased fetal loss in women with heritable thrombophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Increased risk for fetal loss in carriers of the factor V Leiden mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Thrombophilic disorders and fetal loss: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Thrombophilia in pregnancy: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Current practise of testing for inherited thrombophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Updated and revised nomenclature for description of early pregnancy events

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Biology and pathology of the placenta in relation to antiphospholipid antibody-associated pregnancy failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Antiphospholipid antibodies prevent extravillous trophoblast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

The thrombomodulin-protein C system is essential for the maintenance of pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Thrombophilia and pregnancy complications: cause or association?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Inherited thrombophilia and pregnancy complications revisited.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

When are observational studies as credible as randomised trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Systematic reviews in health care: Assessing the quality of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Aspirin plus heparin or aspirin alone in women with recurrent miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications – Yes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

The long and winding road ... towards LMWH for pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications--No

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

Pregnancy failure and heritable thrombophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970028-7

7 January 2021

10.1016/S0049-3848(11)70028-7

Identifiers

DOI

1 reference

15 January 2018

1 reference

15 January 2018